Compounds which potentiate AMPA receptor and uses thereof in medicine
申请人:Harrison Stephen
公开号:US20080045532A1
公开(公告)日:2008-02-21
Compounds of formula (I) and salts are provided:
along with pharmaceutical compositions, uses in medicine, e.g., treating disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment.
Compounds Which Potentiate AMPA Receptor and Uses Thereof in Medicine
申请人:Harrison Stephen
公开号:US20090118280A1
公开(公告)日:2009-05-07
Compounds of formula (I) and salts are provided:
along with pharmaceutical compositions, uses in medicine, e.g., treating disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment.